Breast tissue characterization by in vivo Magnetic Resonance Spectroscopy (MRS)

Spectroscopy

Volumn 25, Issue 6, 2011, Pages 251-260

  Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

biomarker; breast cancer; choline; in vivo; localization; Magnetic resonance spectroscopy (MRS); therapeutic response; water to fat (W F) ratio

Indexed keywords

BIOCHEMISTRY; CHEMOTHERAPY; DIAGNOSIS; DISEASES; HISTOLOGY; MAGNETIC RESONANCE; MAGNETISM; TUMORS;

BREAST CANCER; BREAST TISSUES; CHOLINE; CHOLINE-CONTAINING METABOLITES; IN-VIVO; LOCALISATION; MAGNETIC RESONANCE SPECTROSCOPY; THERAPEUTIC RESPONSE; VIVO MAGNETIC RESONANCE SPECTROSCOPY; WATER-TO-FAT RATIO;

MAGNETIC RESONANCE SPECTROSCOPY;

BIOLOGICAL MARKER; CHOLINE; FAT; WATER;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; HUMAN; IN VIVO STUDY; LIPID ANALYSIS; METABOLITE; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; TREATMENT RESPONSE; TUMOR VOLUME; WATER CONTENT; WATER FAT RATIO;

EID: 80052210144     PISSN: 07124813     EISSN: 1875922X     Source Type: Journal    
DOI: 10.1155/2011/703423     Document Type: Review

References (59)

1. H.M. Baek, J.H. Chen, K. Nie, H.J. Yu, S. Bahri, R.S. Mehta, O. Nalcioglu and M.Y. Su, Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy, Radiology 251 (2009), 653-662.
2. H.M. Baik, M.Y. Su, H. Yu, R. Mehta and O. Nalcioglu, Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T, Magn. Reson. Mater. Phys. MAGMA 19 (2006), 96-104.
3. H.M. Baik, M.Y. Su, H.J. Yu et al., Proton chemical shift imaging for monitoring early treatment response of breast cancer to neoadjuvant chemotherapy, in: Proceedings of the 13th Annual ISMRM, Miami, FL, 2005, p. 1879.
4. L. Bartella and W. Huang, Proton (1H) MR spectroscopy of the breast, Radiographics 27 (2007), S241-S252.
5. L. Bartella, E.A. Morris, D.D. Dershaw, L. Liberman, S.B. Thakur, C. Moskowitz, J. Guido and W. Huang, Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: Preliminary study, Radiology 239 (2006), 686-692. (Pubitemid 43830603)
6. L. Bartella, S.B. Thakur, E.A. Morris, D.D. Dershaw, W. Huang, E. Chough, M.C. Cruz and L. Liberman, Enhancing non-mass lesions in the breast: Evaluation with proton (1H) MR spectroscopy, Radiology 245 (2007), 80-87. (Pubitemid 47417790)
7. P.J. Bolan, L. DelaBarre, E.H. Baker, H. Merkle, L.I. Everson, D. Yee and M. Garwood, Eliminating spurious sidebands in 1H MRS of breast lesions, Magn. Reson. Med. 48 (2002), 215-222. (Pubitemid 34809409)
8. P.J. Bolan, P.G. Henry, E.H. Baker, S. Meisamy and M. Garwood, Measurement and correction of respiration-induced B0 variations in breast 1H MRS at 4 Tesla, Magn. Reson. Med. 52 (2004), 1239-1245. (Pubitemid 39612811)
9. P.J. Bolan, S. Meisamy, E.H. Baker, J. Lin, T. Emory, M. Nelson, L.I. Everson, D. Yee and M. Garwood, In vivo quantification of choline compounds in the breast with 1H MR spectroscopy, Magn. Reson. Med. 50 (2003), 1134-1143. (Pubitemid 37494015)
10. K.M. Cecil, M.D. Schnall and E.S. Siegelman, The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy, Breast Cancer Res. Treat. 68 (2001), 45-54. (Pubitemid 32928270)
11. K.K. Danishad, U. Sharma, R.G. Sah, V. Seenu, R. Parshad and N.R. Jagannathan, Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI), NMR Biomed. 23 (2010), 233-241.
12. H. Degani, A. Horowitz and Y. Itzchak, Breast tumors: Evaluation with P-31 MR spectroscopy, Radiology 161 (1986), 53-55. (Pubitemid 16031426)
13. R. Do, L. Moy, N. Salibi et al., Can MRS improve our ability to distinguish between benign and malignant lesions?, in: Proceedings of the 14th Annual ISMRM, Seattle, WA, 2006, p. 2876.
14. M.D. Dorrius, R.M. Pijnappel, M.C. Jansen-van der Weide, L. Jansen, P. Kappert, M. Oudkerk and P.E. Sijens, Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising non-invasive assessment tool to exclude benign lesions, Radiology 259 (2011), 695-703.
15. T.E. Dzendrowskyj, E.A. Noyszewski, J. Beers and L. Bolinger, Lipid composition changes in normal breast throughout the menstrual cycle, Magn. Reson. Mater. Phys. MAGMA 5 (1997), 105-110. (Pubitemid 27328553)
16. M. Garcia, A. Jemal, E.M. Ward, M.M. Center, Y. Hao, R.L. Siegel and M.J. Thun, Global Cancer Facts and Figures, American Cancer Society, Atlanta, GA, 2007.
17. J. Glaholm, M.O. Leach, D.J. Collins, J. Mansi, J.C. Sharp, A. Madden, I.E. Smith and V.R. McCready, In vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer, Lancet 1 (1989), 1326-1327. (Pubitemid 19151928)
18. K. Glunde, C. Jie and Z.M. Bhujwalla,Molecular causes of the aberrant choline phospholipid metabolism in breast cancer, Cancer Res. 64 (2004), 4270-4276. (Pubitemid 38802433)
19. I.S. Haddadin, A. McIntosh, S. Meisamy, C. Corum, A.L. Styczynski Snyder, N.J. Powell, M.T. Nelson, D. Yee, M. Garwood and P.J. Bolan, Metabolite quantification and high-field MRS in breast cancer, NMR Biomed. 22 (2009), 65-76.
20. J. Hu, Y. Xuan, Z. Latif and R.L. Soulen, An improved 1H magnetic resonance spectroscopic imaging technique for the human breast, in: Proceedings of the 13th Annual ISMRM, Miami, FL, 2005, p. 134.
21. M.A. Jacobs, P.B. Barker, P. Argani, R. Ouwerkerk, Z.M. Bhujwalla and D.A. Bluemke, Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: A feasibility study, J. Magn. Reson. Imaging 21 (2005), 23-28. (Pubitemid 40041416)
22. M.A. Jacobs, P.B. Barker, P.A. Bottomley, Z. Bhujwalla and D.A. Bluemke, Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study, J. Magn. Reson. Imaging 19 (2004), 68-75. (Pubitemid 38055731)
23. N.R. Jagannathan, M. Kumar, P. Raghunathan, O. Coshic, P.K. Julka and G.K. Rath, Assessment of the therapeutic response of human breast carcinoma using in vivo volume localized proton magnetic resonance spectroscopy, Curr. Sci. 76 (1999), 777-782. (Pubitemid 129558264)
24. N.R. Jagannathan, M. Kumar, V. Seenu, O. Coshic, S.N. Dwivedi, P.K. Julka, A. Srivastava and G.K. Rath, Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer, Br. J. Cancer 84 (2001), 1016-1022. (Pubitemid 32448495)
25. N.R. Jagannathan, V. Seenu, M. Kumar, Potential of in vivo proton MRS in assessing breast lesions without the use of contrast agents, Radiology 223 (2002), 281-282. (Pubitemid 34258220)
26. N.R. Jagannathan, M. Singh, V. Govindaraju, P. Raghunathan, O. Coshic, P.K. Julka and G.K. Rath, Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy, NMR Biomed. 11 (1998), 414-422. (Pubitemid 29031851)
27. R. Katz-Brull, P.T. Lavin and R.E. Lenkinski, Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions, J. Natl. Cancer Inst. 94 (2002), 1197-1203. (Pubitemid 34993869)
28. D.W. Klomp, B.L. van de Bank, A. Raaijmakers, M.A. Korteweg, C. Possanzini, V.O. Boer, C.A. van de Berg, M.A. van de Bosch and P.R. Luijten, 31P MRSI and 1H MRS at 7T: initial results in human breast cancer, NMR Biomed. (2011), DOI: 10.1002/nbm.1696 (Epub ahead of print).
29. C. Kuhl, The current status of breast MR imaging. Part I: Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice, Radiology 244 (2007), 356-378. (Pubitemid 47080868)
30. M. Kumar, N.R. Jagannathan, V. Seenu, S.N. Dwivedi, P.K. Julka and G.K. Rath, Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study, J. Magn. Reson. Imaging 24 (2006), 325-332. (Pubitemid 44188558)
31. K.A. Kvistad, I.J. Bakken, I.S. Gribbestad, B. Ehrnholm, S. Lundgren, H.E. Fiosne and O. Haraldseth, Characterization of neoplastic and normal human breast tissues with in-vivo 1H MR spectroscopy, J. Magn. Reson. Imaging 10 (1999), 159-164. (Pubitemid 29362430)
32. M.O. Leach, M. Verrill, J. Glaholm, T.A. Smith, D.J. Collins, G.S. Payne, J.C. Sharp, S.M. Ronen, V.R. McCready, T.J. Powles and I.E. Smith, Measurements of human breast cancer using magnetic resonance spectroscopy: A review of clinical measurements and a report of localized 31P measurements of response to treatment, NMR Biomed. 11 (1998), 314-340. (Pubitemid 28547368)
33. D.J. Manton, A. Chaturvedi, A. Hubbard, M.J. Lind, M. Lowry, A. Maraveyas, M.D. Pickles, D.J. Tozer and L.W. Turnbull, Neoadjuvant chemotherapy in breast cancer: Early response prediction with quantitative MR imaging and spectroscopy, Br. J. Cancer 94 (2006), 427-435. (Pubitemid 43237566)
34. S. Meisamy, P.J. Bolan, E.H. Baker, R.L. Bliss, E. Gulbahce, L.I. Everson, M.T. Nelson, T.M. Emory, D. Yee and M. Garwood, Neoadjuvant chemotherapy of locally advanced breast cancer: Predicting response with in vivo 1H MR spectroscopy-A pilot study at 4 T, Radiology 233 (2004), 424-431. (Pubitemid 39423801)
35. S. Meisamy, P.J. Bolan, E.H. Baker, M.G. Pollema, C.T. Le, F. Kelcz, M.C. Lechner, B.A. Luikens, R.A. Carison, K.R. Brandt, K.K. Amrami, M.T. Nelson, L.I. Everson, T.M. Emory, T.M. Tuttle, D. Yee and M. Garwood, Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: Preliminary results of observer performance study at 4.0 T, Radiology 236 (2005), 465-475. (Pubitemid 41023427)
36. L. Moy, E. Hecht, R. Do et al., Can better breast MR spectroscopy (MRS) be obtained at 3T versus 1.5T?, in: Proceedings of the 92nd Annual Meeting RSNA, Chicago, IL, 2006, p. 652.
37. S.G. Orel andM.D. Schnall, MR imaging of the breast for the detection, diagnosis and staging of breast cancer, Radiology 220 (2001), 13-30. (Pubitemid 32577955)
38. J.M. Park and J.H. Park, Human in vivo 31P MR spectroscopy of benign and malignant breast tumors, Korean J. Radiol. 2 (2001), 80-86. (Pubitemid 33688951)
39. O.M. Redmond, J.P. Stack, N.G. O'Connor, D.N. Carney, P.A. Dervan, B.J. Hurson and J.T. Ennis, 31P MRS as an early prognostic indicator of patient response to chemotherapy, Magn. Reson. Med. 25 (1992), 30-44.
40. J.R. Roebuck, K.M. Cecil, M.D. Schnall and R.E. Lenkinski, Human breast lesions: Characterization with proton MR spectroscopy, Radiology 209 (1998), 269-275. (Pubitemid 28464677)
41. S.M. Ronen and M.O. Leach, Imaging biochemistry: Applications to breast cancer, Breast Cancer Res. 3 (2001), 36-40. (Pubitemid 32223651)
42. J. Ruiz-Cabello and J.S. Cohen, Phospholipid metabolites as indicators of cancer cell function, NMR Biomed. 5 (1992), 226-233.
43. R.G. Sah, U. Sharma, R. Parshad and N.R. Jagannathan, Quantification of absolute concentration of choline for differentiation of malignant, benign and normal breast tissues by in-vivo proton MR spectroscopy, in: Proceedings of the 17th Annual ISMRM, Honolulu, HI, 2009, p. 4236.
44. F. Sardanelli, A. Fausto, G. Di Leo, R. de Nijs, M. Vorbuchner and F. Podo, In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy, AJR Am. J. Roentgenol. 192 (2009), 1608-1617.
45. F. Sardanelli, A. Fausto and F. Podo, MR spectroscopy of the breast, Radiol. Med. (Torino) 113 (2008), 56-64. (Pubitemid 351387211)
46. U. Sharma, H.M. Baek, M.Y. Su and N.R. Jagannathan, In vivo 1H MRS in the assessment of the therapeutic response of breast cancer patients, NMR Biomed. 24 (2011), 700-711.
47. U. Sharma, K.K. Danishad, V. Seenu and N.R. Jagannathan, Longitudinal study of the assessment by MRI and diffusionweighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy, NMR Biomed. 22 (2009), 104-113.
48. U. Sharma and N.R. Jagannathan, In vivo magnetic resonance (MR) spectroscopy in breast cancer, in: Modern Magnetic Resonance, G.A. Webb, ed., Springer, Berlin, 2006, pp. 1063-1072.
49. U. Sharma, M. Kumar, R.G. Sah and N.R. Jagannathan, Study of normal breast tissue by in vivo volume localized proton MR spectroscopy: variation of water-fat ratio in relation to the heterogeneity of the breast and the menstrual cycle, Magn. Reson. Imaging 27 (2009), 785-791.
50. P.E. Sijens, H.K.Wijrdeman, M.A. Moerland, C.J. Bakker, J.W. Vermeulen and P.R. Luyten, Human breast cancer in vivo: 1H and 31P MR spectroscopy at 1.5 T, Radiology 169 (1988), 615-620.
51. B. Sitter, U. Sonnewald,M. Spraul, H.E. Fjosne and I.S. Gribbestad, High-resolution magic angle spinning MRS of breast cancer tissue, NMR Biomed. 15 (2002), 327-337. (Pubitemid 34960100)
52. P. Stanwell, L. Gluch, D. Clark, B. Tomark, L. Baker, B. Giureffe, C. Lean, P. Malycha and C. Mountford, Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1HMRS at 1.5 T, Eur. Radiol. 15 (2005), 1037-1043. (Pubitemid 41166737)
53. M.A. Thomas, N. Binesh, K. Yue and N. De Bruhl, Volume-localized two-dimensional correlated magnetic resonance spectroscopy of human breast cancer, J. Magn. Reson. Imaging 14 (2001), 181-186. (Pubitemid 32709479)
54. M.A. Thomas, N. Wyckoff, K. Yue, N. Binesh, S. Banakar, H.K. Chung, J. Sayre and N. DeBruhl, Two-dimensional MR spectroscopic characterization of breast cancer in vivo, Technol. Cancer Res. Treat. 4 (2005), 99-106. (Pubitemid 40189675)
55. G.M. Tse, D.K. Yeung, A.D. King, H.S. Cheung andW.T. Yang, In vivo magnetic resonance spectroscopy of breast cancer lesions: An update, Breast Cancer Res. Treat. 104 (2007), 249-255. (Pubitemid 47231271)
56. C.J. Twelves, D.A. Porter,M. Lowry, N.A. Dobbs, P.E. Graves, M.A. Smith, R.D. Rubens andM.A. Richards, Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy, Br. J. Cancer 69 (1994), 1151-1156. (Pubitemid 24161878)
57. M. von Goethem, W. Tjalma, K. Schelfout, I. Verslegers, I. Biltjes and P. Parizel, Magnetic resonance imaging in breast cancer, Eur. J. Surg. Oncol. 32 (2006), 901-910. (Pubitemid 44636925)
58. J. Wang, P.L. Torang, T.P. Liu, K.L. Chen and T.T. Shih, Proton MR spectroscopy in normal breasts between pre-And postmenopausal women: A preliminary study, AJR Am. J. Roentgenol. 190 (2008), 505-510. (Pubitemid 351196624)
59. D.K. Yeung, H.S. Cheung and G.M. Tse, Human breast lesions: Characterization with contrast-enhanced in vivo proton MRS-initial results, Radiology 220 (2001), 40-46. (Pubitemid 32577957)